- Home
- QLYS vs MIR Comparison
QLYS vs MIR Comparison
Compare QLYS & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QLYS
- MIR
- Stock Information
- Founded
- QLYS 1999
- MIR 2005
- Country
- QLYS United States
- MIR United States
- Employees
- QLYS N/A
- MIR N/A
- Industry
- QLYS Computer Software: Prepackaged Software
- MIR Industrial Machinery/Components
- Sector
- QLYS Technology
- MIR Technology
- Exchange
- QLYS Nasdaq
- MIR Nasdaq
- Market Cap
- QLYS 4.7B
- MIR 5.2B
- IPO Year
- QLYS 2012
- MIR N/A
- Fundamental
- Price
- QLYS $133.46
- MIR $22.74
- Analyst Decision
- QLYS Hold
- MIR Strong Buy
- Analyst Count
- QLYS 15
- MIR 5
- Target Price
- QLYS $141.00
- MIR $23.00
- AVG Volume (30 Days)
- QLYS 285.3K
- MIR 4.4M
- Earning Date
- QLYS 11-04-2025
- MIR 10-28-2025
- Dividend Yield
- QLYS N/A
- MIR N/A
- EPS Growth
- QLYS 10.84
- MIR N/A
- EPS
- QLYS 5.02
- MIR 0.05
- Revenue
- QLYS $637,019,000.00
- MIR $886,000,000.00
- Revenue This Year
- QLYS $10.58
- MIR $8.46
- Revenue Next Year
- QLYS $6.44
- MIR $7.96
- P/E Ratio
- QLYS $26.61
- MIR $489.53
- Revenue Growth
- QLYS 9.63
- MIR 7.88
- 52 Week Low
- QLYS $112.61
- MIR $9.45
- 52 Week High
- QLYS $170.00
- MIR $23.58
- Technical
- Relative Strength Index (RSI)
- QLYS 49.12
- MIR 60.32
- Support Level
- QLYS $131.22
- MIR $20.98
- Resistance Level
- QLYS $137.00
- MIR $23.58
- Average True Range (ATR)
- QLYS 2.97
- MIR 0.76
- MACD
- QLYS 0.16
- MIR 0.18
- Stochastic Oscillator
- QLYS 37.02
- MIR 76.90
About QLYS Qualys Inc.
Qualys is a cloud security and compliance solutions provider that helps businesses identify and manage their security risks and compliance requirements. The California-based company has more than 10,000 customers worldwide, the majority of which are small- and medium-size businesses. Qualys was founded in 1999 and went public in 2012.
About MIR Mirion Technologies Inc.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.